- Home
- Articles
- latamerica
- disease target
Refine by
Disease Target Articles & Analysis
87 articles found
By enhancing immunogenicity, peptides help create more effective vaccines that provide better disease protection. Peptide Vaccines for Infectious DiseasesPeptide vaccines open new avenues for combating infectious diseases. ...
Applications of Transcriptome Analysis The wide application of transcriptomics in biomedical research is of great significance in understanding the basic mechanisms of life, revealing the molecular mechanisms of disease development, and discovering new therapeutic targets and drugs, including the following directions: Analysis of Gene Expression Regulation l ...
In June 2025, Capstan Therapeutics announced the initiation of a Phase I clinical trial for CPTX2309, an in vivo CAR-T candidate targeting B-cell–mediated autoimmune diseases. The therapy uses targeted lipid nanoparticles (tLNPs) to deliver CAR-encoding mRNA directly to immune cells. ...
Clinical Relevance: From Autoimmunity to Oncology In autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, CCR1 signaling sustains leukocyte infiltration into tissues. Elevated CCR1 expression correlates with disease severity, suggesting it could serve as both biomarker and therapeutic ...
Pathologists and researchers utilize these blocks to conduct histological studies, enabling the identification of kidney diseases, such as glomerulonephritis and diabetic nephropathy. By examining tissue sections under a microscope, scientists can assess changes in kidney morphology and cellular composition, leading to a better understanding of disease ...
Imbalances between ELANE and its inhibitors are central to multiple chronic disease processes, making them a target for therapeutic intervention. ...
These experiments are essential for dissecting the cross-talk between mineralization control and TGF-β superfamily pathways in tissue development and disease. 4. Antibody Development and ELISA Standards Purified recombinant MGP serves as an antigen for monoclonal or polyclonal antibody production. It is also employed as a standard in ELISA kits designed to quantify ...
Dysfunction of podocytes is linked to various kidney diseases, including diabetic nephropathy, focal segmental glomerulosclerosis, and minimal change disease. ...
In recent years, the field of antibody drug design has become increasingly significant in the realm of therapeutic development, driven by the need for more effective and targeted treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. ...
The efficacy of RDCs hinges on the ability to precisely target cancer cells while minimizing effects on normal tissues. 2. Conjugate Design and Synthesis: Once targets are identified, scientists work on creating the drug conjugate. ...
This is particularly crucial for developing targeted therapies and understanding disease mechanisms, as many neurological disorders exhibit species-specific features that limit translatability. ...
” This process can reveal the role of genes in various biological processes, enabling researchers to elucidate the underlying mechanisms of diseases and explore potential therapeutic targets. The creation of custom knockout cell lines involves several advanced techniques, including CRISPR-Cas9, TALENs, and RNA interference. ...
Similarly, in autoimmune and infectious disease studies, cytokine profiling can reveal mechanisms of disease progression and therapeutic targets. ...
These insights are invaluable for optimizing productivity in biotechnology, identifying drug targets in disease research, and understanding complex metabolic disorders. ...
This creates a complex interplay between lipid and metabolite signaling, enhancing the understanding of disease mechanisms and therapeutic targets. Applications of Exosome Lipidomics and Metabolomics The applications of exosome lipidomics and metabolomics extend far beyond basic research into clinical diagnostics and therapeutic interventions. ...
This process enables researchers to identify compounds that can modulate receptor activity, which is particularly relevant in the treatment of various diseases, including cancer, diabetes, and cardiovascular disorders. By observing the effects of different compounds on nuclear receptors, scientists can gain insights into the mechanisms of disease and develop ...
They can be used to identify novel genes related to diseases, screen for potential therapeutic targets, and produce recombinant proteins for therapeutic use. ...
What Is PROTAC Technology? Proteolytic targeting chimera (PROTAC) is a new type of drug design technology that works by inducing the degradation of target proteins. ...
By analyzing these interactions, scientists can identify new biomarkers for disease, develop targeted therapies, or discover novel glycan-binding proteins with potential applications in drug design. 2. ...
This mimetic action allows researchers to enhance or restore the expression of target genes that are otherwise downregulated in diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases. ...